UC Employees: Check Your ESS Access Before Benefits Enrollment Begins

UC employees who are not regular users of

UC Flex Employee Self Service

(ESS) are encouraged to login in anticipation of this year's annual benefits enrollment, which begins Nov. 1. 

Employees should log in with the same credentials (username and password) used for access to UC email, Blackboard and all other Central Log in services at UC.  Benefits enrollment occurs via the Employee Self Service tab.

Off-campus access to UC Flex/ESS requires users to first log into the UC network via VPN.  Click

here

to access the VPN.

To reset your password or if accessing ESS from off campus, call 513-556-HELP (4357).  

Questions pertaining to UC Flex/ESS can be directed to

ucflex@uc.edu

.

Questions on UC’s annual benefit open enrollment can be submitted via email to

HRONESTOP@uc.edu

.

Be sure to check E-currents beginning next week for information about 2016 annual benefits enrollment.

Related Stories

1

The subtle changes in hearing you should never ignore

July 24, 2026

It’s easy to dismiss changes in hearing as minor. But as The Washington Post recently reported, these symptoms could also signal a medical emergency that many people don’t recognize — known as sudden sensorineural hearing loss, a rapid decline in hearing that occurs suddenly or over a few days.

2

UC experts say proper produce washing is key defense against Cyclospora

July 24, 2026

Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.

3

What are the options for male birth control?

July 24, 2026

Despite major advances in contraception during the past several decades, responsibility for pregnancy prevention falls largely on women. As recently reported in Endocrinology Advisor, a new generation of male contraceptive candidates is advancing into early- and mid-stage clinical trials.